Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (60)
Guidance programme
(
1 selected
)
Guidance programme
Clinical guidelines (1)
Diagnostics guidance (2)
Health technology evaluations (1)
Interventional procedures guidance (3)
NICE guidelines (1)
Technology appraisal guidance (60)
Apply filters
Showing 11 to 20 of 60
Sort by
Date
Title
Apply sorting
lung cancer
Remove lung cancer filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Durvalumab for maintenance treatment of unresectable non-small-cell
lung cancer
after platinum-based chemoradiation
TA798
22 June 2022
22 June 2022
Tepotinib for treating advanced non-small-cell
lung cancer
with MET gene alterations
TA789
18 May 2022
18 May 2022
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell
lung cancer
TA781
30 March 2022
30 March 2022
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell
lung cancer
TA770
9 February 2022
9 February 2022
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell
lung cancer
after complete tumour resection
TA761
19 January 2022
19 January 2022
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell
lung cancer
TA760
12 January 2022
12 January 2022
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell
lung cancer
TA724
8 September 2021
8 September 2021
Nivolumab for advanced non-squamous non-small-cell
lung cancer
after chemotherapy
TA713
7 July 2021
7 July 2021
Atezolizumab monotherapy for untreated advanced non-small-cell
lung cancer
TA705
2 June 2021
2 June 2021
Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell
lung cancer
TA683
10 March 2021
10 March 2021
Previous page
1
Current page
2
3
4
5
6
Page
2
of
6
Next page
Results per page
10
25
50
All
Back to top